Pravastatin for Prevention of Preeclampsia

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

February 12, 2024

Study Completion Date

February 12, 2024

Conditions
Preeclampsia
Interventions
DRUG

Pravastatin

Comparison of different drug dosages. Women will be instructed to take a pravastatin pill everyday starting the day of randomization and ending the day of delivery. The women will be divided into three cohorts. Each cohort will receive one of the following doses of pills: 10mg or 20mg or 40mg.

DRUG

Placebo

Women will be instructed to take a placebo pill daily beginning the day of randomization and ending the day of delivery.

Trial Locations (3)

15213

University of Pittsburgh, Pittsburgh

60611

Northwestern University, Chicago

77555

University of Texas Medical Branch, Galveston

All Listed Sponsors
collaborator

University of Pittsburgh

OTHER

collaborator

Northwestern University

OTHER

collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

The University of Texas Medical Branch, Galveston

OTHER

NCT01717586 - Pravastatin for Prevention of Preeclampsia | Biotech Hunter | Biotech Hunter